GALEOTTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.887
AS - Asia 4.289
EU - Europa 3.743
SA - Sud America 579
Continente sconosciuto - Info sul continente non disponibili 152
AF - Africa 139
OC - Oceania 47
Totale 18.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.673
SG - Singapore 1.358
GB - Regno Unito 1.339
CN - Cina 830
IT - Italia 810
HK - Hong Kong 461
BR - Brasile 404
VN - Vietnam 369
DE - Germania 271
BD - Bangladesh 261
SE - Svezia 250
TR - Turchia 233
FI - Finlandia 184
FR - Francia 176
IN - India 133
RU - Federazione Russa 122
UA - Ucraina 121
KR - Corea 111
CA - Canada 110
ID - Indonesia 102
AR - Argentina 73
JP - Giappone 71
BG - Bulgaria 69
PL - Polonia 53
MX - Messico 52
PK - Pakistan 49
GR - Grecia 40
TH - Thailandia 40
IR - Iran 39
MY - Malesia 36
AU - Australia 34
CH - Svizzera 33
ES - Italia 33
NL - Olanda 33
CL - Cile 28
LT - Lituania 28
IQ - Iraq 26
RS - Serbia 26
ZA - Sudafrica 26
TN - Tunisia 24
CO - Colombia 23
DZ - Algeria 23
EG - Egitto 22
AT - Austria 19
PT - Portogallo 19
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 18
BE - Belgio 17
MA - Marocco 17
UZ - Uzbekistan 17
RO - Romania 16
DK - Danimarca 15
PH - Filippine 15
QA - Qatar 15
NZ - Nuova Zelanda 13
VE - Venezuela 13
IE - Irlanda 12
EC - Ecuador 11
LB - Libano 11
SI - Slovenia 11
TW - Taiwan 11
CR - Costa Rica 10
IL - Israele 10
NP - Nepal 10
PE - Perù 9
HR - Croazia 8
AZ - Azerbaigian 7
BO - Bolivia 7
ET - Etiopia 7
JO - Giordania 7
CZ - Repubblica Ceca 6
EU - Europa 6
HN - Honduras 6
JM - Giamaica 6
UY - Uruguay 6
KE - Kenya 5
MO - Macao, regione amministrativa speciale della Cina 5
AL - Albania 4
CU - Cuba 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KZ - Kazakistan 4
MK - Macedonia 4
NG - Nigeria 4
NO - Norvegia 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
UG - Uganda 4
AM - Armenia 3
BY - Bielorussia 3
BZ - Belize 3
GT - Guatemala 3
NI - Nicaragua 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GE - Georgia 2
Totale 18.659
Salva come PNG Salva come JPEG
Città #
Ashburn 1.038
Singapore 989
Southend 944
Santa Clara 765
Fairfield 717
Woodbridge 466
Chandler 458
Hong Kong 447
San Jose 422
Houston 317
Council Bluffs 311
Seattle 288
Cambridge 235
Wilmington 223
Dearborn 222
Beijing 221
Nyköping 210
London 169
Jacksonville 156
Ann Arbor 151
Modena 141
Helsinki 132
Los Angeles 122
New York 119
Ho Chi Minh City 109
The Dalles 100
Hefei 86
Hanoi 84
Izmir 81
Atlanta 71
Dallas 70
Redwood City 61
Sofia 61
Jakarta 59
Seoul 58
Milan 56
Princeton 56
Eugene 54
Columbus 46
Lauterbourg 45
Buffalo 44
Rome 43
San Diego 43
Leipzig 41
Shanghai 41
Dong Ket 40
Istanbul 38
Tokyo 38
São Paulo 35
Chicago 32
Moscow 32
Munich 30
Hillsboro 26
Bangkok 24
San Francisco 24
Orem 23
Belgrade 22
Denver 22
Mexico City 22
Ankara 21
Chennai 21
Phoenix 21
Naples 20
Nuremberg 20
Boardman 19
Guangzhou 18
Jinan 18
Turku 18
Belo Horizonte 17
Falkenstein 17
Florence 17
Redondo Beach 17
Montreal 16
Washington 16
Bologna 15
Doha 15
Frankfurt am Main 15
Haiphong 15
Parma 15
Stockholm 15
Tashkent 15
Brooklyn 14
Brussels 14
Manchester 14
Rio de Janeiro 14
Warsaw 14
Amsterdam 13
Basingstoke 13
Boston 13
Delhi 13
Falls Church 13
Madrid 13
Paris 13
Turin 13
Athens 12
Curitiba 12
Kunming 12
San Giuliano Milanese 12
Zhengzhou 12
Brasília 11
Totale 11.606
Salva come PNG Salva come JPEG
Nome #
Oral bioavailability and pharmacokinetic of non-animal chondroitin sulfate and its constituents in healthy male volunteers 1.882
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 744
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 737
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 646
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 521
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 494
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 368
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 365
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 358
Comparative analysis of fatty acid profile in three eutardigrade species 353
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 351
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 350
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 343
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 342
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 335
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 331
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 323
Recent advances on separation and characterization of human milk oligosaccharides. 317
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 311
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 311
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 305
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 305
Isolation and structural characterization of chondroitin sulfate from bony fishes 305
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 302
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 290
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 288
Human milk glycosaminoglycans: the state of the art and future perspectives 286
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 280
PURIFICATION OF PROPOLIS FROM POLYCYCLIC AROMATIC HYDROCARBONS AND PRESERVATION OF ACTIVE POLYPHENOL COMPONENT. 277
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 276
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 274
Glycosaminoglycan profiling as a novel pan-cancer minimally invasive systems biomarker. 270
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 269
High quality Green (Brazilian) propolis extracts characterized for active biomolecules exert epigenetic effects able to have a positive influence on cell oxidative stress 267
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 266
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 264
Mucopolysaccharidosis type II: preliminary data on glycosaminoglycan levels and structure in mice at baseline and after 6 weeks treatment with ERT 263
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 260
Human milk glycosaminoglycans. Handbook on dietary and nutritional aspects of human breast milk 248
Breast Cyst Fluid Heparan Sulfate is Distinctively N-sulfated Depending on Apocrine or Flattened Type 245
Water Soluble Ppropolis (Greit120) and Human Interferon – α (HuIFN-AlfaN3) shows Anti – Influenza virus activity in vitro 242
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 241
Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process 235
Plasma glycosaminoglycan scores in early stage renal cell carcinoma 226
Chemical composition and antioxidant activity of propolis prepared in different forms and in different solvents useful for finished products 223
Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization. 221
High-throughput determination of urinary hexosamines in newborns of 2-3 days of age: application for the early diagnosis of mucopolysaccharidoses 221
Selective removal of keratan sulfate in chondroitin sulfate samples by sequential precipitation with ethanol 219
Approccio globale alle mucopolisaccaridosi: creazione piattaforma web-based 216
Determination of total and single species of all uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for a possible early diagnosis of mucopolysaccharidoses 213
CHARACTERIZED PROPOLIS EXTRACTS, OBTAINED WITH STANDARDIZED EXTRACTION METHOD, SHOWN SIMILAR CHEMICAL PROFILE (HPLC-ESI-MSN) AND IN VITRO ANTIBACTERIAL, ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY TROUGH EVALUATION OF EXPRESSION OF miRNAS, mRNAS AND PROTEINS 201
Rigon L, Maccari F, Salvalaio M, Legnini E, D’Avanzo F, Galeotti F, Mantovani V, Gabrielli O, Marin O, Scarpa M, Volpi N, Tomanin R. Glycosaminoglycan profile in the Mucopolysaccharidosis type II mouse model at baseline and after 6 weeks treatment with ERT 188
Propolis: innovation and new applications based on its fine structural composition 176
Variazioni del dermatan solfato plasmatico durante la terapia enzimatica sostitutiva con iduronato-2-solfatasi in un paziente affetto da mucopolisaccaridosi II 174
Human milk glycosaminoglycan composition from women of different countries: a pilot study 168
Noninvasive detection of any-stage cancer using free glycosaminoglycans 138
Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer 117
Mucopolisaccaridosi: approcci analitici alla diagnosi asintomatica. 95
Totale 18.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.990
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022822 0 0 0 53 32 55 46 44 169 106 171 146
2022/20231.368 128 147 103 147 113 192 25 179 152 24 67 91
2023/20241.163 49 67 44 178 237 102 115 136 27 41 63 104
2024/20252.689 100 76 56 184 541 397 183 198 299 112 212 331
2025/20264.901 174 96 299 416 767 303 633 286 501 508 445 473
2026/20272.707 1.636 459 387 225 0 0 0 0 0 0 0 0
Totale 18.836